Samwise Healthcare IT Newsletter
Saturday, June 13, 2026
Tech Industry Layoffs Hit Healthcare IT as Oracle Finalizes 30,000 Cuts
Oracle is set to complete approximately 30,000 layoffs by June 15 per WARN filings, continuing a wave of AI-driven workforce reductions that has reshaped health technology employment across the first half of 2026. Innovaccer laid off more than 300 employees following its acquisition of CaduceusHealth, while Salesforce eliminated 86 positions including staff on its Agentforce AI team. Meanwhile, athenahealth announced plans to offer its electronic health record customers direct access to Agentforce, a move that illustrates how AI is simultaneously reducing headcount and expanding vendor product offerings across the sector.
Sources: Healthcare IT News
Interoperability’s Hidden Divide: Sensitive Records Leave Vulnerable Patients Behind
Healthcare interoperability has quietly created a disparity: patients with sensitive records—behavioral health histories and substance use disclosures—must choose between sharing all data or opting out entirely. Dr. Hannah Galvin, chief health information officer at Cambridge Health Alliance in Massachusetts, says the architecture produces “meaningfully-lower-quality care” for those populations. Her nonprofit, Shift, cofounded in 2018 and formalized two years later, is developing standards-based data segmentation to enable selective record-sharing. Funding remains the primary barrier. A patchwork of state privacy shield laws is now accelerating industry movement toward a national interoperable standard.
Sources: Becker’s Hospital Review
Bipartisan Report: Most Clinical AI Escapes Federal Oversight Framework
Most health AI tools in everyday clinical use fall outside the regulatory framework providers and patients might expect, according to a Bipartisan Policy Center report. The most common applications—ambient scribes and insurer prior authorization tools—are not FDA-regulated medical devices. Oversight instead fragments across the FDA, CMS, HHS Office for Civil Rights, the Federal Trade Commission, and ONC, with additional state-level variation on top. Regulatory complexity and unclear reimbursement pathways are dampening investment in higher-stakes clinical AI, while a new administration proposal to roll back ONC’s AI transparency requirements has raised liability concerns among providers.
Sources: Becker’s Hospital Review
Curated by JD · samwise.agency